Literature DB >> 21244618

Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats.

B Pellicer1, S Herraiz, O Cauli, R Rodrigo, M Asensi, J Cortijo, V Serra, E Morcillo, V Felipo, C Simón, A Pellicer.   

Abstract

OBJECTIVE: To determine the effects of chronic administration of sildenafil citrate on healthy pregnant rats.
DESIGN: In vivo animal experimental study.
SETTING: Fundación IVI-Instituto Universitario IVI, Valencia, Spain. SAMPLE: Pregnant and non-pregnant Wistar rats exposed to chronic administration of sildenafil.
METHODS: Placental cross-barrier and feto-maternal relationship levels, maternal blood pressure, and haemodymamic effects on uterine arteries were evaluated. The effect of growth on weight and fetal tissues, and on perinatal outcome, was investigated. MAIN OUTCOME MEASURES: Maternal blood pressure, blood viscosity, vascular indices of uterine arteries and fetal ductus venosus, plasmatic levels of sildenafil, embryo/fetal and litter weights, perinatal/postnatal survival rates.
RESULTS: Sildenafil citrate crossed the placenta. The maternal and fetal levels of sildenafil, and its metabolite desmethyl-sildenafil, demonstrated a positive linear correlation in treated pregnant animals versus controls; a selective maternal hypotensive effect without changes in uterine vascular resistance was noted on days E8 and E11 (embryonic day). The lower pulsatility index of the ductus venosus on day E18 suggests fetal overflow at the end of the pregnancy. Effects on offspring were placental and liver enlargement, and increased fetal weight gain in the second half of pregnancy (irrespective of liver enlargement) and at birth. Perinatal and postnatal survival rates in the sildenafil group remained unaltered. No haemodynamic effects were evident in non-pregnant animals.
CONCLUSIONS: In normotensive rats, sildenafil appears to have a selective effect at the onset of pregnancy, implying increased fetal blood supply, and increased fetal weight, and placental and liver enlargement, but no increased perinatal mortality.
© 2011 The Authors Journal compilation © RCOG 2011 BJOG An International Journal of Obstetrics and Gynaecology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244618     DOI: 10.1111/j.1471-0528.2010.02839.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

1.  Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain.

Authors:  Omar Cauli; Alba González-Usano; Andrea Cabrera-Pastor; Carla Gimenez-Garzó; Pilar López-Larrubia; Amparo Ruiz-Sauri; Vicente Hernández-Rabaza; Malgorzata Duszczyk; Michal Malek; Jerzy W Lazarewicz; Arturo Carratalá; Amparo Urios; Alfonso Miguel; Isidro Torregrosa; Carmen Carda; Carmina Montoliu; Vicente Felipo
Journal:  Neuromolecular Med       Date:  2013-12-13       Impact factor: 3.843

2.  Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype.

Authors:  Mark Robert Dilworth; Irene Andersson; Lewis James Renshall; Elizabeth Cowley; Philip Baker; Susan Greenwood; Colin Peter Sibley; Mark Wareing
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

3.  Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.

Authors:  Anouk Pels; Janus C Jakobsen; Wessel Ganzevoort; Christiana A Naaktgeboren; Wes Onland; Aleid G van Wassenaer-Leemhuis; Christian Gluud
Journal:  Trials       Date:  2019-01-11       Impact factor: 2.279

4.  Antenatal sildenafil citrate treatment increases offspring blood pressure in the placental-specific Igf2 knockout mouse model of FGR.

Authors:  L J Renshall; E C Cottrell; E Cowley; C P Sibley; P N Baker; E B Thorstensen; S L Greenwood; M Wareing; M R Dilworth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-06       Impact factor: 4.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.